- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Du Pont drops suit against Syncor
Only weeks after filing a patent infringement suit against marketing partner Syncor International, Du Pont Pharmaceuticals this month terminated the litigation. In a joint press release, the two companies announced that their dispute has been resolved.
Only weeks after filing a patent infringement suit against marketing partner Syncor International, Du Pont Pharmaceuticals this month terminated the litigation. In a joint press release, the two companies announced that their dispute has been resolved. The conflict was a misunderstanding, according to Robert Funari, president and CEO of Syncor. The firms declined to provide further details on the matter.
The decision brings a quick end to a tussle that surprised market watchers. On June 17, North Billerica, MA-based Du Pont filed suit against Syncor with the Mexican Institute of Industrial Property, alleging that Syncors subsidiary, Syncor de Mexico, has illegally bought and sold Cardiolite kits, including counterfeit Cardiolite, in Mexico (SCAN 8/4/99). Syncor of Woodland Hills, CA, issued a strong denial of the charges, and filed a defense.
Both companies emphasized the importance of their U.S. relationship in resolving the dispute. The two firms rely heavily on each other: Syncor has been Du Ponts primary U.S. distributor of Cardiolite since the products launch, and distributes more than 80% of the unit doses sold in the U.S.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
